Cover
Cover | Apr. 25, 2024 |
Document Information [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 25, 2024 |
Entity File Number | 001-36288 |
Entity Registrant Name | Akari Therapeutics, Plc |
Entity Central Index Key | 0001541157 |
Entity Tax Identification Number | 98-1034922 |
Entity Incorporation, State or Country Code | X0 |
Entity Address, Address Line One | 22 Boston Wharf Road FL 7 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
City Area Code | 929 |
Local Phone Number | 274-7510 |
Written Communications | true |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
ADR [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | American Depository Shares, each representing 2,000 Ordinary Shares |
Trading Symbol | AKTX |
Security Exchange Name | NASDAQ |
Ordinary Shares, par value $0.0001 per share [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Ordinary Shares, par value $0.0001 per share* |
No Trading Symbol Flag | true |